4.7 Article

Radiotherapy Induces Innate Immune Responses in Patients Treated for Prostate Cancers

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Surgery

Meta-Analysis of the Prognostic and Clinical Value of Tumor-Associated Macrophages in Hepatocellular Carcinoma

Jie Zhang et al.

Summary: Tumor-associated macrophages (TAMs) play a crucial role in the cancer microenvironment. This meta-analysis found that a high density of M2 TAMs is associated with poor prognosis in hepatocellular carcinoma (HCC), while CD68(+)M1 TAMs do not have prognostic effects on overall survival. CD206(+)M2 TAMs may serve as a prognostic biomarker for HCC, but further studies with larger sample sizes are needed to confirm these findings.

JOURNAL OF INVESTIGATIVE SURGERY (2021)

Review Multidisciplinary Sciences

Macrophage targeting in cancer

Martha Lopez-Yrigoyen et al.

Summary: Tumorigenesis is influenced by interactions between cancer cells and the tumor microenvironment. Tumor-associated macrophages play a crucial role in tumor development, with the potential to both promote antitumor responses and exhibit immunosuppressive protumor phenotypes. Targeting TAMs has become a strategy in cancer therapy, with a focus on reprogramming TAMs to support antitumor immune responses.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2021)

Article Oncology

The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells

Nicholas G. Nickols et al.

Summary: The study indicates that stereotactic body radiotherapy causes a significant shift from lymphoid to myeloid immune infiltrate in the prostate, which may be important when combining SBRT with immunotherapies, especially in prostate cancer.

PROSTATE CANCER AND PROSTATIC DISEASES (2021)

Review Immunology

Radiation-Induced Immunity and Toxicities: The Versatility of the cGAS-STING Pathway

Julie Constanzo et al.

Summary: Radiation therapy has transitioned into the era of personalized medicine in the past decade, but the challenge now lies in identifying the optimal radiation regimen to induce a clinically relevant anti-tumor immune response. Organs at risks and tumor microenvironment components often limit the effectiveness of radiation therapy, highlighting the importance of understanding immune response in tumor control and treatment optimization.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

Nucleic Acid Immunity and DNA Damage Response: New Friends and Old Foes

Clara Taffoni et al.

Summary: The maintenance of genomic stability in multicellular organisms relies on DNA damage response (DDR), which not only repairs genomic lesions but also plays a role in inflammatory responses. The crosstalk between pattern recognition receptors (PRRs) and DDR proteins influences innate immune activation, potentially impacting pathological outcomes. Understanding the molecular determinants of this cooperation will be crucial for future therapeutic approaches.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

The Prognostic Potential of Human Prostate Cancer-Associated Macrophage Subtypes as Revealed by Single-Cell Transcriptomics

Joseph C. Siefert et al.

Summary: Through single-cell transcriptomic analysis of prostate cancer resident macrophages, three distinct populations were identified, with a gene signature highly associated with patient prognosis. This highlights the relevance of tissue-specific macrophage subtypes in the tumor microenvironment for prostate cancer progression.

MOLECULAR CANCER RESEARCH (2021)

Review Oncology

The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy?

Sonja S. Mojsilovic et al.

Summary: Apart from transformed cells, tumors consist of various cell types, with tumor-associated macrophages (TAMs) being the most abundant innate immune cells in the tumor microenvironment (TME). TAMs within the TME exhibit high plasticity and undergo specific functional metabolic alterations depending on the availability of tumor tissue oxygen and nutrients, further contributing to tumorigenesis and cancer progression.

ANALYTICAL CELLULAR PATHOLOGY (2021)

Review Cell Biology

Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor-Glioma Therapy?

Ni Tong et al.

Summary: TAMs play a crucial role in the progression of glioma, and treatment strategies targeting TAMs include inhibiting recruitment, reducing viability, and altering phenotype. Research progress has shown the potential effectiveness of anti-tumor therapy targeting TAMs.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Oncology

Revisiting Immunotherapy: A Focus on Prostate Cancer

Ha-Ram Cha et al.

CANCER RESEARCH (2020)

Review Biochemistry & Molecular Biology

DNA Damage Response and Immune Defense

Claudia Nastasi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer

Quinn Storozynsky et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Dentistry, Oral Surgery & Medicine

Regulatory T cells and M2-polarized tumour-associated macrophages are associated with the oncogenesis and progression of oral squamous cell carcinoma

A. Kouketsu et al.

INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2019)

Review Immunology

Targeting Tumor-Associated Macrophages in Cancer

Paulina Pathria et al.

TRENDS IN IMMUNOLOGY (2019)

Review Immunology

Re-education of macrophages as a therapeutic strategy in cancer

Joanna Kowal et al.

IMMUNOTHERAPY (2019)

Review Biochemistry & Molecular Biology

Tumor Microenvironment as A Game Changer in Cancer Radiotherapy

Magdalena Jarosz-Biej et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Immunology

The Metabolic Signature of Macrophage Responses

Antonella Viola et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Oncology

An Antitumor Immune Response Is Evoked by Partial-Volume Single-Dose Radiation in 2 Murine Models

Ela Markovsky et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

Article Medicine, General & Internal

Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer

Amar U. Kishan et al.

JAMA NETWORK OPEN (2019)

Review Oncology

The Metabolic Landscape of Prostate Cancer

Francesca Giunchi et al.

EUROPEAN UROLOGY ONCOLOGY (2019)

Review Oncology

Using immunotherapy to boost the abscopal effect

Wilfred Ngwa et al.

NATURE REVIEWS CANCER (2018)

Review Oncology

The immune contexture in cancer prognosis and treatment

Wolf H. Fridman et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Review Oncology

Tumour-associated macrophages as treatment targets in oncology

Alberto Mantovani et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Review Biochemistry & Molecular Biology

Macrophage biology plays a central role during ionizing radiation-elicited tumor response

Qiuji Wu et al.

BIOMEDICAL JOURNAL (2017)

Article Biochemical Research Methods

Reactome pathway analysis: a high-performance in-memory approach

Antonio Fabregat et al.

BMC BIOINFORMATICS (2017)

Article Oncology

TH2-Polarized CD4+ T Cells and Macrophages Limit Efficacy of Radiotherapy

Stephen L. Shiao et al.

CANCER IMMUNOLOGY RESEARCH (2015)

Review Immunology

Metabolic Regulation of Immune Responses

Kirthana Ganeshan et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)

Article Oncology

Proctitis following stereotactic body radiation therapy for prostate cancer

Daniel Y. Joh et al.

RADIATION ONCOLOGY (2014)

Review Biochemistry & Molecular Biology

Redox regulation of the immune response

Johanna M. Gostner et al.

REDOX REPORT (2013)

Article Multidisciplinary Sciences

Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery

Larry Gold et al.

PLOS ONE (2010)

Review Oncology

CLINICAL RADIATION SENSITIVITY WITH DNA REPAIR DISORDERS: AN OVERVIEW

Julianne M. Pollard et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)

Review Oncology

Systemic effects of local radiotherapy

Silvia C. Formenti et al.

LANCET ONCOLOGY (2009)